BE884722A - Nouvel ester mixte symetrique de 1,2,3-trihydroxypropane, son procede d'obtention et ses applications therapeutiques - Google Patents

Nouvel ester mixte symetrique de 1,2,3-trihydroxypropane, son procede d'obtention et ses applications therapeutiques

Info

Publication number
BE884722A
BE884722A BE2/58700A BE2058700A BE884722A BE 884722 A BE884722 A BE 884722A BE 2/58700 A BE2/58700 A BE 2/58700A BE 2058700 A BE2058700 A BE 2058700A BE 884722 A BE884722 A BE 884722A
Authority
BE
Belgium
Prior art keywords
trihydroxypropane
therapeutic applications
mixed ester
obtaining same
novel symmetric
Prior art date
Application number
BE2/58700A
Other languages
English (en)
Original Assignee
Es De Especialidades Farmaco T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Es De Especialidades Farmaco T filed Critical Es De Especialidades Farmaco T
Publication of BE884722A publication Critical patent/BE884722A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE2/58700A 1980-02-15 1980-08-12 Nouvel ester mixte symetrique de 1,2,3-trihydroxypropane, son procede d'obtention et ses applications therapeutiques BE884722A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES488665A ES8101585A1 (es) 1980-02-15 1980-02-15 Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico

Publications (1)

Publication Number Publication Date
BE884722A true BE884722A (fr) 1980-12-01

Family

ID=8479833

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2/58700A BE884722A (fr) 1980-02-15 1980-08-12 Nouvel ester mixte symetrique de 1,2,3-trihydroxypropane, son procede d'obtention et ses applications therapeutiques

Country Status (3)

Country Link
BE (1) BE884722A (fr)
ES (1) ES8101585A1 (fr)
FR (1) FR2476095A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
WO2008112166A2 (fr) 2007-03-09 2008-09-18 Indigene Pharmaceuticals Inc. Combinaison de metformine r-(+) lipoate et d'agents antihyperlipidémiques pour le traitement de l'hyperglycémie diabétique et de complications diabétiques
US7732413B2 (en) 2003-03-07 2010-06-08 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7741289B2 (en) 2003-03-07 2010-06-22 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2020243590A1 (fr) 2019-05-30 2020-12-03 Intercept Pharmaceuticals, Inc. Compositions pharmaceutiques comprenant un agoniste de fxr et un fibrate pour une utilisation dans le traitement d'une maladie hépatique cholestatique
US11311557B2 (en) 2015-02-06 2022-04-26 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions for combination therapy

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692262B1 (fr) * 1992-06-10 1994-08-05 Adir Nouveaux nicotinates de diacylglycerols, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7732413B2 (en) 2003-03-07 2010-06-08 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7741289B2 (en) 2003-03-07 2010-06-22 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2008112166A2 (fr) 2007-03-09 2008-09-18 Indigene Pharmaceuticals Inc. Combinaison de metformine r-(+) lipoate et d'agents antihyperlipidémiques pour le traitement de l'hyperglycémie diabétique et de complications diabétiques
US11311557B2 (en) 2015-02-06 2022-04-26 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions for combination therapy
EP4035665A1 (fr) 2015-02-06 2022-08-03 Intercept Pharmaceuticals, Inc. Compositions pharmaceutiques pour thérapie combinée
WO2020243590A1 (fr) 2019-05-30 2020-12-03 Intercept Pharmaceuticals, Inc. Compositions pharmaceutiques comprenant un agoniste de fxr et un fibrate pour une utilisation dans le traitement d'une maladie hépatique cholestatique

Also Published As

Publication number Publication date
ES488665A0 (es) 1980-12-16
FR2476095A1 (en) 1981-08-21
FR2476095B1 (fr) 1984-03-09
ES8101585A1 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
OA06914A (fr) Procédé de préparation d'iminodiacides substitués.
FR2581323B1 (fr) Nouvelle composition tensio-active, son procede d'obtention et ses applications
FR2556210B1 (fr) Prothese veineuse et son procede d'obtention
FR2474039B1 (fr) Procede de preparation de polymeres d'a-olefines
RO83549A (fr) Suspension stable de polymeres hydrosolubles et procede d'obtention
BE886862A (fr) Dispositifs biomedicaux de separation et procede d'obtention
BE850855A (fr) Procede de preparation d'homopolymeres et copolymeres d'alpha-mono-olefines
BE862106A (fr) Procede de preparation d'electro-corindon fondu
BE888578A (fr) Composition de sec-butylbiphenyle et procede d'obtention,
BE884722A (fr) Nouvel ester mixte symetrique de 1,2,3-trihydroxypropane, son procede d'obtention et ses applications therapeutiques
FR2510604B1 (fr) Production d'activateur de plasminogene
FR2529879B1 (fr) Procede d'expansion de la perlite et produit obtenu
BE881609A (fr) Procede de production et d'isolement de methyltertiobutylether
RO82681A (fr) Composition en base de polymere hydrosoluble et procede d'obtention
LU79426A1 (fr) Compositions purifiees d'urokinase et procede pour leur obtention
BE891532A (fr) Procede de preparation d'ethyleneglycol et de ses ethers, et produits ainsi obtenus
BE873008A (fr) Procede de preparation de polymeres contenant de l'hexacarbonyl-tungstene et polymeres ainsi obtenus
FR2474052B1 (fr) Nouvelle collagenase, procede d'obtention et applications
BE890629A (fr) Procede de preparation d'acetaldehyde
BE871536A (fr) Masse d'enduction et son procede de preparation
FR2492663B1 (fr) Produit medicamenteux regulateur du t-systeme de l'immunite et son procede de preparation
FR2601955B1 (fr) Procede de preparation d'alkyl et d'arylchlorosilane
RO80055A2 (fr) Composition medicamenteuse antiacneique,antiseboreique et antiactinique et procede d'obtention
FR2559492B1 (fr) Mousses de matieres polymeriques et leur procede d'obtention
PT67027B (fr) Procede et installation pour la preparation d'engrais

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SOCIEDAD ESPANOLA DE ESPECIALIDADES FARMACO-TERAP

Effective date: 19940831